SNWV
SANUWAVE Health Inc.
SNWV's fundamentals are mixed: it returned to profit, but its operating margin went from 17% to −1.1%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
SNWV Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Stable | |
| Healthy | |
| Strong |
SNWV's cash flow and balance sheet are currently healthy, and its profitability is stable, but its revenue is under pressure.
SNWV PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 1.2x | $1.58 | — |
| Current | 4.3x | $1.58 | — |
| Cheap | 4.4x | $1.63 | +3.2% |
| Fair | 4.9x | $1.81 | +15% |
| Expensive | 5.7x | $2.10 | +33% |
Historical ranges are pointers, not guarantees.
SNWV's PE is 4.3x, but its earnings don't support one, so it isn't a reliable read right now.
SNWV Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Decline | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect SNWV's earnings to grow and its profitability to improve, but its revenue to decline.
SNWV Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.28 | +247% |
| Q3 2024 | $4.76 | +$31.01 |
| Q2 2024 | $0.00 | +$15.00 |
| Q1 2024 | -$3.75 | +$7.50 |
| Q4 2023 | -$11.25 | -$3.75 |
| Q3 2023 | -$26.25 | -$18.75 |
| Q2 2023 | -$15.00 | -$3.75 |
| Q1 2023 | -$11.25 | +$7.50 |
| Q4 2022 | -$7.50 | +$11.25 |
SNWV has returned to profit: it earned $0.37 per share over the past year, after losing money the year before.
SNWV Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $8.6M | -25% |
| Q2 2026 | $9.7M | -4.2% |
| Q1 2026 | $9.6M | +3% |
| Q4 2025 | $13.4M | +30% |
| Q3 2025 | $11.5M | +22% |
| Q2 2025 | $10.2M | +42% |
| Q1 2025 | $9.3M | +61% |
| Q4 2024 | $10.3M | +48% |
SNWV's revenue has held roughly level: $9M last quarter, down 25% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -13% | -25 points |
| Q2 2026 | -2.9% | -21 points |
| Q1 2026 | -12% | -22 points |
| Q4 2025 | 15% | -9.5 points |
| Q3 2025 | 13% | -8.1 points |
| Q2 2025 | 18% | -9.3 points |
| Q1 2025 | 11% | +29 points |
| Q4 2024 | 24% | +9.6 points |
SNWV's operating margin was −13% last quarter, down 25 points from the same quarter a year ago.
SNWV Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.1M | -296% |
| Q2 2026 | $91K | +$257K |
| Q1 2026 | $374K | +$2.1M |
| Q4 2025 | $3.2M | +538% |
| Q3 2025 | $556K | -55% |
| Q2 2025 | -$166K | +$594K |
| Q1 2025 | -$1.7M | -270% |
| Q4 2024 | $505K | +$1.8M |
SNWV's free cash flow has turned positive after six years mostly in the red: $3M over the past year.
SNWV Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +1.1K shares |
| 1 year | -5.9% | -538K shares |
| 3 years | +487% | +7.1M shares |
| 5 years | +739% | +7.6M shares |
SNWV has 9M diluted shares, down 5.9% from a year ago.
SNWV Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -8.0x | Net Cash |
| Q2 2026 | -2.8x | Net Cash |
| Q1 2026 | 1.9x | Healthy |
| Q4 2025 | 1.4x | Healthy |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | -1.0x | Net Cash |
| Q1 2025 | -1.0x | Net Cash |
| Q3 2024 | 0.9x | Very low |
SNWV has more cash than debt.
SNWV Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 24.2 | Oversold |
| Stochastic | 16.7 | Oversold |
SNWV's weekly RSI is 24 (oversold) and its Stochastic is 17 (oversold).
SNWV PE vs Healthcare Sector
| Metric | SNWV | Sector median | Relative |
|---|---|---|---|
| PE | 4.3x | 26x | 83% below |
| PE % | 12 | 29 | 17 pts below |
SNWV is trading at 4.3x earnings, a 83% discount to the Healthcare sector's median of 26x, though its earnings don't support one.
SNWV Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.32 | 63% below |
| 20 week MA | $5.42 | 71% below |
| 50 week MA | $15.2 | 90% below |
| 100 week MA | $23.5 | 93% below |
| 200 week MA | $16.3 | 90% below |
SNWV is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
SNWV Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $61.9 | $79.7 | +29% |
| 2021 | $79.7 | $56.3 | -29% |
| 2022 | $56.3 | $10.5 | -81% |
| 2023 | $10.5 | $4.87 | -54% |
| 2024 | $4.87 | $23.0 | +371% |
| 2025 | $23.0 | $30.5 | +33% |
| 2026 YTD | $30.5 | $1.58 | -95% |
SNWV's yearly returns have swung widely, from +371% in 2024 to −81% in 2022. It's down 95% so far in 2026.